Macrocyclic diterpenes of natural origin are able to reverse multidrug resistance in cancer

send to a friend share this

Macrocyclic diterpenes of natural origin are able to reverse multidrug resistance in cancer

Tuesday, 09.08.2016

Authors and Affiliations:
Mariana Alves Reisa, Omar Bauomy Ahmedb, Gabriella Spenglerc, Joseph Molnárc, Hermann Lageb,d and Maria-José U Ferreiraa

a Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Avenue Prof. Gama Pinto, 1649-003 Lisbon, Portugal

b Institute of Pathology, University Hospital Charité, 10117 Berlin, Germany

c Department of Medical Microbiology and Immunobiology, Faculty of Medicine, University of Szeged, Dómtér 10, H-6720 Szeged, Hungary

d Department of Pathology, Vivantes Clinics, Berlin, Germany

 

Abstract:

Background: Modulation of P-glycoprotein (ABCB1) and evaluation of the collateral sensitivity effect are among the most promising approaches to overcome multidrug resistance (MDR) in cancer. In a previous study, two rare 12,17-cyclojatrophanes (1–2) and other novel jatrophanes (3–4), isolated from Euphorbia welwitschii, were screened for collateral sensitivity effect. Herein, the isolation of another jatrophane (5) is presented, being the broader goal of this work to investigate the role of euphowelwitschines A (1) and B (2), welwitschene (3), epoxywelwitschene (4) and esulatin M (5) as ABCB1 modulators and/or collateral sensitivity agents.

Methods: Compounds 1–5 were evaluated for ABCB1 modulation ability through combination of transport and chemosensitivity assays, using a mouse T-lymphoma MDR1 -transfected cell model. Moreover, the nature of interaction of compound 4 with ABCB1 was studied, using an ATPase assay. The MDR-selective antiproliferative activity of compound 5 was evaluated against gastric (EPG85-257) and pancreatic (EPP85-181) human cancer cells and their drug-selected counterparts (EPG85-257RDB, EPG85-257RNOV, EPP85-181RDB, EPP85-181RNOV). The drug induced cell death was investigated for compounds 4 and 5, using the annexin V/PI staining and the active caspase-3 assay.

Results: The jatrophanes 1–5 were able to modulate the efflux activity of ABCB1, and at 2 µM, 3–5 maintained the strong modulator profile. Structure activity results indicated that high conformational flexibility of the twelve-membered ring of compounds 3–5 favored ABCB1 modulation, in contrast to the tetracyclic scaffold of compounds 1 and 2. The effects of epoxywelwitschene (4) on the ATPase activity of ABCB1 showed it to interact with the transporter and to be able to reduce the transport of a second substrate. Drug combination experiments also corroborated the anti-MDR potential of these diterpenes due to their synergistic interaction with doxorubicin (combination index < 0.7). Esulatin M (5) showed a strong MDR-selective antiproliferative activity against EPG85-257RDB and EPP85-181RDB cells, with IC 50 of 1.8 and 4.8 µM, respectively. Compounds 4 and 5 induced apoptosis via caspase-3 activation. A significant discrimination was observed between the resistant cell lines and parental cells.

Conclusions: This study strengthens the role of jatrophane diterpenes as lead candidates for the development of MDR reversal agents, highlighting the action of compounds 4 and 5. 

Journal: Phytomedicine

http://dx.doi.org/10.1016/j.phymed.2016.05.007